A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Ertapenem for the Treatment of Foot Infections in Subjects With Diabetes
A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Ertapenem for the Treatment of Foot Infections in Subjects With Diabetes
The purpose of this study was to look at the safety and effectiveness of a once-daily dose of tigecycline compared to ertapenem for the treatment of diabetic foot infections. The co-primary efficacy endpoints were not met.
Main inclusion criteria:
Main exclusion criteria:
Buenos Aires, Buenos Aires CP 1428, Argentina
Holargos, Athens, 11527, Greece
Rio-Patras, 265 04, Greece
Colonia El Ritiro, Guadalajara 44280, Mexico
Lasi, 700111, Romania
Banska.Bysterica, 97517, Slovakia
Getafe Madrid, 28905, Spain
Copenhagen, 2400, Sweden
Taoyuan Hsien, Taiwan
Capa-Istanbul, 34390, Turkey (Türkiye)